Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. |
|---|---|
| Authors: | Blauvelt A; Oregon Medical Research Center, Portland., Teixeira HD; AbbVie Inc, North Chicago, Illinois., Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland., Costanzo A; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy., De Bruin-Weller M; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands., Barbarot S; Department of Dermatology, Nantes Université, Centre Hospitalier Universitaire de Nantes, Nantes, France., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Division of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Division of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada., Lio P; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Medical Dermatology Associates of Chicago, Chicago, Illinois., Hu X; AbbVie Inc, North Chicago, Illinois., Wu T; AbbVie Inc, North Chicago, Illinois., Liu J; AbbVie Inc, North Chicago, Illinois., Ladizinski B; AbbVie Inc, North Chicago, Illinois., Chu AD; AbbVie Inc, North Chicago, Illinois., Eyerich K; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. |
| Source: | JAMA dermatology [JAMA Dermatol] 2021 Sep 01; Vol. 157 (9), pp. 1047-1055. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34347860 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Blauvelt+A%22">Blauvelt A</searchLink>; Oregon Medical Research Center, Portland.<br /><searchLink fieldCode="AU" term="%22Teixeira+HD%22">Teixeira HD</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Simpson+EL%22">Simpson EL</searchLink>; Department of Dermatology, Oregon Health & Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Costanzo+A%22">Costanzo A</searchLink>; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22De+Bruin-Weller+M%22">De Bruin-Weller M</searchLink>; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Barbarot+S%22">Barbarot S</searchLink>; Department of Dermatology, Nantes Université, Centre Hospitalier Universitaire de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Prajapati+VH%22">Prajapati VH</searchLink>; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Division of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Division of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Lio+P%22">Lio P</searchLink>; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Medical Dermatology Associates of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Wu+T%22">Wu T</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Ladizinski+B%22">Ladizinski B</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Chu+AD%22">Chu AD</searchLink>; AbbVie Inc, North Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Eyerich+K%22">Eyerich K</searchLink>; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2021 Sep 01; Vol. 157 (9), pp. 1047-1055. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34347860 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamadermatol.2021.3023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1047 Titles: – TitleFull: Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Blauvelt A – PersonEntity: Name: NameFull: Teixeira HD – PersonEntity: Name: NameFull: Simpson EL – PersonEntity: Name: NameFull: Costanzo A – PersonEntity: Name: NameFull: De Bruin-Weller M – PersonEntity: Name: NameFull: Barbarot S – PersonEntity: Name: NameFull: Prajapati VH – PersonEntity: Name: NameFull: Lio P – PersonEntity: Name: NameFull: Hu X – PersonEntity: Name: NameFull: Wu T – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Ladizinski B – PersonEntity: Name: NameFull: Chu AD – PersonEntity: Name: NameFull: Eyerich K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2021 Sep 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2168-6084 Numbering: – Type: volume Value: 157 – Type: issue Value: 9 Titles: – TitleFull: JAMA dermatology Type: main |
| ResultId | 1 |